Real-World Experience with TRK Inhibitors in Patients with Lung and Colon Cancers

Ezra Cohen, MD, FRCPSC, FASCO; Mary Jo Fidler, MD; Arturo Loaiza-Bonilla, MD, MSEd, FACP

Video Categories: NTRK Gene Fusions

Dr Mary Fidler of Rush University Medical Center, Chicago, IL, and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, describe their practical experiences with TRK inhibitors in patients with lung cancer and colorectal cancer.

January 30, 2014

Personalized Medicine and Drug Development/Approval

Listen as Dr Agarwala presents how developments in personalized medicine will impact and change the way drugs are developed and approved.

September 7, 2018

Why Are Clinical Trials Important?

Dr Andrey Antov believes it’s important for patients to participate in clinical trials for a multitude of reasons, as clinical trials can benefit both the patient and the healthcare system as a whole.